Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma

BACKGROUND: Neutrophils play a controversial role in tumor development. The function of programmed cell death-1 ligand (PD-L1(+)) neutrophils, however, may inhibit the cytotoxicity of anti-tumor immunity. In this study, we elucidate the stimulators of PD-L1(+) neutrophils in tumor microenvironment (...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Haijing, Kan, Anna, Lyu, Ning, He, Meng, Huang, Xin, Qiao, Shuang, Li, Shaolong, Lu, Wenhua, Xie, Qiankun, Chen, Huiming, Lai, Jinfa, Chen, Qifeng, Jiang, Xiongying, Liu, Shousheng, Zhang, Zhenfeng, Zhao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231064/
https://www.ncbi.nlm.nih.gov/pubmed/34168004
http://dx.doi.org/10.1136/jitc-2020-002305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231064/
https://www.ncbi.nlm.nih.gov/pubmed/34168004
http://dx.doi.org/10.1136/jitc-2020-002305

Ejemplares similares